AstraZeneca PLC is 111.4x more valuable than Disc Medicine, Inc. by market capitalization ($286.27 B vs $2.57 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IRON | AZN |
|---|---|---|
| Market cap | $2.57 B | $286.27 B |
| US-listed rank | #1924 | #45 |
| Net income (latest FY) | -$212.18M | - |
| SEC filings | 704 | 1,004 |
AstraZeneca PLC is 111.4x more valuable than Disc Medicine, Inc. by market capitalization ($286.27 B vs $2.57 B).
Full pages: Disc Medicine, Inc. and AstraZeneca PLC, or browse the full rankings.